Abstract
This study assesses a 2-gene RNA signature that can be translated into a rapid (<25 minutes) and portable laboratory-on-a-chip platform suitable for development as a point-of-care test.
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Bacterial Infections / blood
-
Bacterial Infections / diagnosis*
-
Biomarkers / blood
-
Child
-
Diagnosis, Differential
-
Humans
-
Oligonucleotide Array Sequence Analysis
-
Point-of-Care Testing*
-
RNA / blood*
-
Receptors, Virus / genetics*
-
Sensitivity and Specificity
-
Tumor Suppressor Proteins / genetics*
-
Virus Diseases / blood
-
Virus Diseases / diagnosis*
Substances
-
Biomarkers
-
IFI44L protein, human
-
Receptors, Virus
-
Tumor Suppressor Proteins
-
RNA